What Is Polypharmacy?
Polypharmacy typically refers to use of five or more medications. It’s common among:
Older adults, Patients with multiple chronic conditions,Individuals seeing multiple specialists.
According to World Health Organization, medication-related harm is among the leading causes of preventable injury in healthcare worldwide.
Why Drug–Drug Interactions are Hidden.
Many interactions don’t cause immediate or dramatic symptoms. Instead, they may appear as:
Fatigue or confusion, Falls or dizziness,
Poor disease control (e.g., uncontrolled blood pressure or glucose),Organ toxicity developing over time.
Common Types of Drug–Drug Interactions
1. Pharmacokinetic Interactions
One drug alters how another is absorbed, metabolized, or eliminated.
Example: A medication that inhibits liver enzymes can raise blood levels of another drug to toxic ranges.
2. Pharmacodynamic Interactions
Two drugs have additive or opposing effects.
Examples include:
*Multiple sedatives → excessive drowsiness and fall risk.
*Several blood-thinning agents → increased bleeding.
3. Therapeutic Duplication
Different medications from the same class are prescribed unintentionally, offering no added benefit but higher risk.
Who Is Most at Risk?
Polypharmacy-related DDIs are most common in:
Adults above 60, Patients with kidney or liver disease,Those taking narrow therapeutic-index drugs.
Practical Strategies to Reduce Risk
★Regular Medication Reviews,
★ Deprescribing When Appropriate,
★ Use Interaction-Checking Tools,
★ Improve Care Coordination,
★ Patient Education.
CONCLUSION
In polypharmacy patients, drug–drug interactions are often silent, cumulative, and preventable. Proactive medication management through regular reviews, deprescribing, and interprofessional collaboration is one of the most effective ways to reduce avoidable harm and improve outcomes.
Role of pharmacists in managing polypharmacy